共 17 条
[1]
Drummond M., Brandt A., Luce B., Et al., Standardising methodologies for economic evaluation in health care. Practice, problems and potential, Int J Technol Assess Health Care, 9, 1, pp. 26-36, (1993)
[2]
Drummond M.F., Stoddart G.L., Torrance G.W., Methods for the economic appraisal of health care programmes, (1987)
[3]
Bootman J.L., Larson L.N., McGhan W.F., Et al., Pharmacoeconomics research and clinical trials: concepts and issues, PharmacoEconomics, 23, (1989)
[4]
Diamond G.A., Denton T.A., Matloff J.M., Fee-for-benefit: a strategy to improve the quality of health care and control costs through reimbursement incentives, J Am Coll Cardiol, 22, (1993)
[5]
Lunde P.K.M., Baksaas I., Epidemiology of drug utilisation: basic concepts and methodology, Acta Med Scand, 721, pp. 7-11, (1987)
[6]
Maxwell M., Heaney D., Howie J.G.R., Et al., General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method, BMJ, 307, (1993)
[7]
Szuba T.J., Westerholm B., Studies on drug utilization: bilateral case study in Poland and Sweden, Soc Sci Med, 29, (1989)
[8]
Hopley P.J., Piercy J., Information on the public health from PACT data, Pharm J, 6657, (1991)
[9]
Clarke K.W., Gray D., Hampton J.R., Defined daily doses: insensitive in determining disease prevalence, Pharm J, 252, (1994)
[10]
Papoz L., Utilisation of drug sales data for the epidemiology of chronic diseases: the example of diabetes, Epidemiology, 4, (1993)